A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/29/2001	US20010045213 Method of treating diabetes mellitus in a patient
11/29/2001	DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression
11/29/2001	DE10025948A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025946A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025890A1 Dosierung von transdermalen Arzneimittelsystemen Dose of transdermal drug delivery systems
11/29/2001	DE10025162A1 Production of alcoholic approximately b-carotene-containing oil-in-water or water-in-oil emulsions for use in the production of liqueurs such as advocaat
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	DE10021894A1 Easily applied pharmaceutical composition for diagnosis and treatment of erectile dysfunction, comprises mixture of active agent, e.g. prostaglandin E1, and carrier forming gel in urethra
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410563A1 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	CA2410401A1 A novel treatment for cough
11/29/2001	CA2410336A1 Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410219A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	CA2410014A1 Medicaments for treating colics
11/29/2001	CA2410004A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001	CA2409950A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
11/29/2001	CA2409907A1 Combination sis and vacuum bandage and method
11/29/2001	CA2409830A1 Sulfonamide derivatives
11/29/2001	CA2409777A1 Continuous production of pharmaceutical granulates
11/29/2001	CA2409688A1 Method for improving the cell protection
11/29/2001	CA2409603A1 System and method for assessing the performance of a pharmaceutical agent delivery system
11/29/2001	CA2409592A1 Pharmceutical compositions comprising vip-related peptides for the treatment of sexual disorders
11/29/2001	CA2409051A1 Antimigraine combination comprising sapindus and emblica extracts
11/29/2001	CA2408781A1 Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
11/29/2001	CA2408777A1 Dosage of transdermal delivery systems
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408033A1 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	CA2407958A1 Crystalline polymeric compositions for ophthalmic devices
11/29/2001	CA2407784A1 Treatment of acute coronary syndrome with glp-1
11/29/2001	CA2407767A1 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/29/2001	CA2407764A1 O/w emulsion
11/29/2001	CA2405459A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/28/2001	EP1158021A1 Microgels and external preparations containing the same
11/28/2001	EP1158014A1 Process for producing polymer
11/28/2001	EP1157749A2 Metered dose inhaler for albuterol
11/28/2001	EP1157726A1 Reactive crystallization method to improve particle size
11/28/2001	EP1157703A2 Sustained release of peptides from pharmaceutical compositions
11/28/2001	EP1157702A1 Compositions comprising DNA Damaging Agents and p53
11/28/2001	EP1157691A1 Pullulan film compositions with improved surface properties
11/28/2001	EP1157690A1 Sustained release pharmaceutical composition
11/28/2001	EP1157689A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
11/28/2001	EP1157688A1 Antibacterial aqueous ophthalmic formulations containing ofloxacin and chitosan
11/28/2001	EP1157682A1 Blister package for topiramate tablets
11/28/2001	EP1156831A1 Painless and tissue-conserving injection of medicaments
11/28/2001	EP1156829A1 Stable formulation containing fumagillin
11/28/2001	EP1156812A1 Multiparticulate formulation
11/28/2001	EP1156809A1 Mucin containing ophthalmic preparations
11/28/2001	EP1156806A1 Pharmaceutical composition containing proton pump inhibitors
11/28/2001	EP1156797A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/28/2001	EP1156793A2 Oral drug delivery system
11/28/2001	EP1156790A1 Combinations of formoterol and mometasone furoate for asthma
11/28/2001	EP1156789A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/28/2001	EP1156788A1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
11/28/2001	EP1156786A1 Orally dispersible tablet with low friability and method for preparing same
11/28/2001	EP1156785A1 Rapidly-soluble compositions
11/28/2001	EP1156784A1 Processes for making pharmaceutical oral ecb formulations and compositions
11/28/2001	EP1156783A1 Encapsulation of bioactive complexes in liposomes
11/28/2001	EP1156782A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/28/2001	EP1156781A2 Microemulsions with adsorbed macromoelecules and microparticles
11/28/2001	EP1156770A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
11/28/2001	EP1054685B1 Liquid crystal forms of cyclosporin
11/28/2001	EP0991407B1 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
11/28/2001	EP0837710B1 Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
11/28/2001	EP0817622B1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
11/28/2001	EP0804225B1 Pharmaceutical compositions comprising a superoxide dismutase
11/28/2001	EP0773783B1 Preparation of fusidic acid tablets
11/28/2001	EP0758244B1 Controlled-release dosage forms of azithromycin
11/28/2001	EP0708671B1 Drug delivery
11/28/2001	EP0684819B1 Liquid pharmaceutical compositions based on ibuprofen
11/28/2001	CN2461545Y 'Huaduling' tablet structure
11/28/2001	CN2461544Y Self-heating medicinal plaster
11/28/2001	CN1324377A Urethane (meth) acrylates contg. siloxane groups and able to undergo free-radical polymerisation
11/28/2001	CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324257A Vaporizing device for administering sterile medication
11/28/2001	CN1324253A Vapour dispensing device
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
11/28/2001	CN1324235A Compositions of and process for producing isotretinoin having low particle size
11/28/2001	CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
11/28/2001	CN1324232A Expandable gastroretentive therapeutic system with prolonged stomach retention time
11/28/2001	CN1323631A Paralysis treating medicine bolus
11/28/2001	CN1323630A Licorice powder producing process
11/28/2001	CN1323625A Hypolycemic traditional Chinese medicine composite
11/28/2001	CN1323612A Mihaigao ointment made of honey, sepium and other traditional Chinese medicine and its prepn.
11/28/2001	CN1323610A Proriasis treating Yinxieling capsule
11/28/2001	CN1323606A Wound curing and swelling-eliminating tranditional Chinese medicine ointment and its pharmaceutical application
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323600A Compound cassia seed eye drops
11/28/2001	CN1323598A Antifatigue capsule
11/28/2001	CN1323586A Formulation and production process of bee glue capsule
11/28/2001	CN1323582A Prepn. of injecta powder containing tannic acid component
11/28/2001	CN1323579A Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/28/2001	CN1075386C Method for producing Anruneixiao medicinal liquid
11/28/2001	CN1075383C Bone-setting and muscle-jointing-up medicine and prepn. method thereof
11/28/2001	CN1075378C Traditional Chinese medicine emulsion for anti cancer and prepn. method thereof

1 ... 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 ... 2991